: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%.
: Following a 2011 French study linking the drug to bladder cancer, medical authorities in France and Germany suspended or banned the use of Actos. ACTOS RECALL
While there have been significant legal and international developments, it is important to clarify that . : In June 2011, the FDA issued a
We use cookies to optimise site functionality and give you the best possible experience.